Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 120Carcinoma, Hepatocellular 69Ovarian Neoplasms 64Neoplasms 36Carcinoma, Non-Small-Cell Lung 35Fallopian Tube Neoplasms 29Brain Neoplasms 24Glioblastoma 23Colonic Neoplasms 21Breast Neoplasms 19Endometrial Neoplasms 18Neoplasm Metastasis 17Uterine Cervical Neoplasms 15Stomach Neoplasms 15Rectal Neoplasms 15Lung Neoplasms 14Liver Neoplasms 11Triple Negative Breast Neoplasms 10Melanoma 8Glioma 8Carcinoma, Renal Cell 8Carcinoma, Ovarian Epithelial 8Biliary Tract Neoplasms 8Recurrence 7Colorectal Cancer Metastatic 7Squamous Cell Carcinoma of Head and Neck 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Advanced Solid Tumors 6Small Cell Lung Carcinoma 5Pancreatic Neoplasms 5

Interventions

pembrolizumab 5Nivolumab 3durvalumab 2tremelimumab 1relatlimab 1fludarabine phosphate 1fludarabine 1avelumab 1atezolizumab 1Therapeutics 1Temozolomide 1Surgical Procedures, Operative 1Neoadjuvant Therapy 1Ipilimumab 1Injections 1Docetaxel 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Bevacizumab 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Microsatellite Instability × Bevacizumab × 1 year × Clear all
NCT06004245 2026-05-08

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

Vividion Therapeutics, Inc.

Phase 1 Recruiting
280 enrolled
Gastrointestinal

Colorectal Neoplasms, Microsatellite Instability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡